To decode the growth vs. value debate, Lombard Odier Investment Managers (LOIM) analysed growth, population, productivity and capex across regions.
Florian Ielpo, Head of Macro, Multi asset, at LOIM, highlights the findings in short: “When productivity drives the cycle, it usually benefits growth stocks. Conversely, a cycle driven more by capital expenditure tends to weigh on growth stocks and benefits quality stocks.”
Read the full assessment here.
Read more

Columbia Threadneedle Investments
What’s next for the US in 2025?
US equities remain attractive despite high valuations, but rising government debt could pose a threat to bond markets.

Quant Investing
AI and quantitative investing
Artificial intelligence applications go way beyond stock selection.

Schroders
Looking ahead: 30-year return forecasts
Higher returns are expected across asset classes, driven by stronger productivity growth for equities and elevated long-term central bank rate projections for bonds.

Bellevue Asset Management
Demographics and AI drive MedTech stocks
MedTech investment case: What makes it attractive, which trends stand out?